Valuation: MiniMed Group, Inc.

Market Cap 4.57B 4.17B 3.86B 3.49B 6.55B 427B 6.85B 46.64B 18.5B 231B 17.16B 16.8B 731B P/E 2027 *
24.7x
P/E 2028 * 21.4x
Enterprise Value 4.31B 3.92B 3.63B 3.28B 6.16B 402B 6.45B 43.89B 17.41B 217B 16.15B 15.81B 688B EV / Sales 2027 *
1.25x
EV / Sales 2028 * 1.07x
Free-Float
99.4%
Yield 2027 *
-
Yield 2028 * -
1 day-4.30%
1 week-9.03%
Current month-11.05%
1 month-8.60%
3 months-19.58%
6 months+49.31%
1 week 16.14
Extreme 16.135
19.11
1 month 16.14
Extreme 16.135
19.92
Current year 10.65
Extreme 10.65
24.43
1 year 10.65
Extreme 10.65
24.43
3 years 10.65
Extreme 10.65
24.43
5 years 10.65
Extreme 10.65
24.43
10 years 10.65
Extreme 10.65
24.43
Date Insider Type Main position Quantity % Market Cap. Importance
10/28/26 Tax

Chief Technology Officer

-449 0.0002%
10/15/26 Free

Director

11,877 0.0042%
10/15/26 Free

Director

3,374 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
-4.30%-9.03% - - 4.57B
-0.58%-3.15%-17.66%+4.34% 180B
-0.11%-0.38%+0.27%+34.58% 123B
-1.59%+0.22%-14.04%+8.57% 119B
+0.51%-2.55%-42.90%+0.63% 89.18B
-2.03%-2.33%-5.40%+75.00% 65.12B
-1.57%-1.40%+11.22%-8.83% 57.93B
-1.26%-1.20%-1.07%+48.73% 54.33B
-2.91%-4.35%-0.82%+38.03% 48.88B
-0.76%+2.28%+3.09%-0.38% 36.07B
Average -1.46%-1.42%-7.48%+22.30% 78B
Weighted average by Cap. -0.95%-1.13%-10.77%+19.36%

Financials

2027 *2028 *
Net sales 3.44B 3.13B 2.9B 2.62B 4.92B 321B 5.15B 35.03B 13.89B 173B 12.89B 12.62B 549B 3.73B 3.4B 3.14B 2.84B 5.34B 348B 5.58B 38.01B 15.08B 188B 13.99B 13.69B 596B
Net income 186M 169M 157M 142M 266M 17.35B 278M 1.89B 751M 9.38B 697M 682M 29.7B 239M 218M 202M 182M 342M 22.34B 358M 2.44B 967M 12.07B 897M 878M 38.23B
Net Debt -269M -245M -227M -205M -385M -25.15B -403M -2.75B -1.09B -13.59B -1.01B -989M -43.05B -583M -532M -492M -445M -835M -54.49B -874M -5.95B -2.36B -29.45B -2.19B -2.14B -93.28B
Projected Income Statement - Annual - MiniMed Group, Inc.
Logo MiniMed Group, Inc.
MiniMed Group, Inc. is an insulin delivery company advancing automated therapy for people with diabetes. Its fully integrated system addresses pain points for people with diabetes (PWD): health outcomes and complexity of diabetes management. The MiniMed 780G is its flagship AID system. The MiniMed 780G system uses its SmartGuard dosing algorithm technology, which automatically delivers basal insulin and auto-correction doses every five minutes based on sensor glucose readings. The MiniMed 780G consists of the MiniMed 780G insulin pump, the Simplera Sync CGM sensor, and the instinct sensor. Its platform of clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and a Smart Multiple Daily Injection (MDI) System. Its pipeline products are the MiniMed Flex, screenless insulin pump, next-generation Vivera dosing algorithm, and MiniMed Fit patch pump with extended wear.
Employees
-
Date Price Change Volume
26-11-19 US$16.26 -4.30% 6,972,807
26-11-18 US$16.99 -4.44% 4,705,390
26-11-17 US$17.78 -4.66% 5,027,275
26-11-16 US$18.65 +3.67% 10,719,687
26-11-13 US$17.99 +0.64% 5,376,895
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - MiniMed Group, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
16.26USD
Average target price
25.33USD
Spread / Average Target
+55.80%
  1. Stock Market
  2. Stocks
  3. MMED Stock